Park S, JM Ahn, Lee K, Kwon O, Park H, Yoon YH, Kang DY, Lee PH, Lee SW, Park SW, Park DW, Park SJ. Long-term (10-year) outcomes of stenting or bypass surgery for acute coronary syndromes and stable ischemic heart disease with unprotected left main coronary artery disease. Am Heart J. 2019 Dec;218:9-19.
Park S, Park GM, Ha J, Cho YR, Roh JH, Park EJ, Yang Y, Won KB, Ann SH, Kim YG, Kim SJ, Lee SG, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee SW, Kim YH. Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individuals. PLoS One. 2020 Apr 8;15(4):e0231428.
Park S, Ahn JM, Kim TO, Park H, Kang DY, Lee PH, Jeong YJ, Hyun J, Lee J, Kim JH, Yang Y, Choe K, Park SJ, Park DW. Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction. J Am Coll Cardiol. 2020 Sep 22;76(12):1395-1406.
Park S, Ahn JM, Kim TO, Park H, Cho SC, Kang DY, Lee PH, Park DW, Park SJ. Incidence and Impact of Thrombocytopenia in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. Am J Cardiol. 2020 Nov 1;134:55-61.
Park S, Kim YG, Ann SH, Park HW, Suh J, Roh JH, Cho YR, Han S, Park GM. Angiotensin-Converting Enzyme Inhibitor-based Versus Angiotensin Receptor Blocker-based Optimal Medical Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study. J Cardiovasc Pharmacol. 2021 Jan 1;77(1):61-68.
Park S, Ahn JM, Park H, Kang DY, Lee PH, Kim TO, Lee J, Kim JH, Yang Y, Jeong YJ, Hyun J, Kim AR, Kim T, Oh HJ, Lee YJ, Lee JH, Jang M, Park DW, Park SJ. Comparison of Long-Term Outcomes Following Coronary Revascularization in Men-vs-Women with Unprotected Left Main Disease. Am J Cardiol. 2021 Aug 15;153:9-19.
Park S, Kim YG, Ann SH, Park HW, Suh J, Roh JH, Cho YR, Han S, Park GM. Ticagrelor versus prasugrel in patients with acute myocardial infarction. Int J Cardiol. 2021 Dec 1;344:25-30.
Park S, Park SJ, Park DW. Percutaneous Coronary Intervention for Left Main Coronary Artery Disease: Present Status and Future Perspectives. JACC Asia. 2022 Mar 15;2(2):119-138.
Park S, Park SJ, Park DW. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Revascularization of Left Main Coronary Artery Disease. Korean Circ J. 2023 Mar;53(3):113-133.
Park S, Kim YG, Ann SH. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population. Epidemiol Health. 2023:45:e2023052.
Park S, Jeon YJ, Ann SH. Comprehensive Prediction of Subclinical Coronary Atherosclerosis in Subjects Without Traditional Cardiovascular Risk Factors. Am J Cardiol. 2023 Jul 1:198:64-71.
Park S, Chang JH, Hong SP. Impact of Trimetazidine on the Incident Heart Failure After Coronary Artery Revascularization. J Cardiovasc Pharmacol. 2023 Oct 1;82(4):318-326.
